Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives, Eur Respir J, vol.53, 2019. ,
Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur Respir J, vol.53, 2019. ,
,
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Respir J, vol.46, pp.903-975, 2015. ,
Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension, Ann Thorac Surg, vol.104, pp.404-411, 2017. ,
New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication, Chest, vol.147, pp.529-537, 2015. ,
New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways, Curr Opin Pulm Med, vol.23, pp.377-385, 2017. ,
Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia, Circulation, vol.113, pp.1857-1864, 2006. ,
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents, Am J Respir Crit Care Med, vol.186, pp.666-676, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00905191
Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension, Am J Respir Cell Mol Biol, vol.45, pp.311-322, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00579959
Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex, Am J Respir Crit Care Med, vol.192, pp.983-997, 2015. ,
Leptin signalling system as a target for pulmonary arterial hypertension therapy, Eur Respir J, vol.45, pp.1066-1080, 2015. ,
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension, J Clin Invest, vol.128, pp.1956-1970, 2018. ,
Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth musclelike cells in pulmonary hypertension, Circulation, vol.129, pp.1586-1597, 2014. ,
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension, J Med Chem, vol.61, pp.2725-2736, 2018. ,
Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization, Am J Physiol Lung Cell Mol Physiol, vol.297, pp.1082-1090, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00499633
Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations, Expert Opin Ther Targets, vol.21, pp.181-190, 2017. ,
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension, Circ Res, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02007505
Resident PW1+ Progenitor Cells Participate in Vascular Remodeling During Pulmonary Arterial Hypertension, Circ Res, vol.118, pp.822-833, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01304194
Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension, Sci Transl Med, vol.7, pp.308-159, 2015. ,
Cell Autonomous and Non-cell Autonomous Regulation of SMC Progenitors in Pulmonary Hypertension, Cell Rep, vol.23, pp.1152-1165, 2018. ,
Loss of Endothelial Derived WNT5A is Associated with Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension, Circulation, 2018. ,
Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension, Am J Pathol, vol.186, pp.2500-2514, 2016. ,
Neutralization of CXCL12 reverses established pulmonary hypertension in the sugen-hypoxia rat model, Eur Respir J, vol.50, p.2385, 2017. ,
Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay, Circulation, vol.129, pp.1332-1340, 2014. ,